In the first two instalments of our Axis for Change series we discussed the fragmented diagnostic ecosystem and the barriers that currently prevent many patients from gaining access to the appropriate tests and, in turn, the appropriate treatment.
In this third report of the series, we take a more forward-thinking approach that celebrates the ongoing, disruptive achievements that are reshaping the testing landscape and building a foundation for a new era of patient testing, finally unlocking the promise of precision medicine. We also call for significantly greater levels of investment in the diagnostic pathway to give more patients the opportunity to access the optimal treatment.